Veradermics, Incorporated (MANE) Stock Overview
Explore Veradermics, Incorporated’s financial performance, market position, analyst ratings, and future outlook.
Veradermics, Incorporated (MANE)
Key Financials
Key Financials
Market Cap
4.6B
P/E Ratio
-71.24
EPS (TTM)
$-3.14
ROE
-0.84%
MANE Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Veradermics, Incorporated (NYSE: MANE) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Veradermics, Incorporated's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MANE on the NYSE shows an RSI of 50.05, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $122.62 for the NYSE listing.
Key metrics behind Veradermics, Incorporated's NYSE-traded stock include a P/E ratio of -71.24 and a market capitalization of 4.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MANE on the NYSE.